Literature DB >> 242201

Effects of benzodiazepines on central serotonergic mechanisms.

L Stein, C D Wise, J D Belluzzi.   

Abstract

If the rat conflict test were a valid animal model of anxiety neurosis, evidence which implicates serotonin systems in the anxiety-reducing actions of benzodiazepine tranquilizers could be summarized as follows: (1) The punishment-lessening effects of benzodiazepines in the conflict test are mimicked by serotonin antagonists (methysergide, cinanserin, bromolysergic acid), serotonin synthesis inhibition (PCPA), and serotonin nerve terminal damage (5,6-dihydroxytryptamine). (2) Punishment effects may be intensified by the serotonin precursor, 5-hydroxytryptophan (in combination with a monoamine oxidase inhibitor), serotonin agonists (alpha-methyltryptamine), or intraventricular injections of serotonin itself. Intraventricularly administered serotonin also antagonizes the punishment-lessening effects of benzodiazepines. (3) Stimulation of the serotonergic cell bodies in the dorsal raphe nucleus by local application of crystalline carbachol causes intense suppression of behavior. The suppressive effects of raphe stimulation are antagonized by systemic administration of benzodiazepines. (4) In biochemical experiments, the decrease in norepinephrine turnover induced by oxazepam rapidly undergoes tolerance, whereas the decrease induced in serotonin turnover is maintained over repeated doses. These results parallel findings in the conflict test which indicate that the depressant action of oxazepam rapidly undergoes tolerance, whereas the anxiety-reducing action is maintained over repeated doses. Although central serotonin neurons are thus implicated in the therapeutic actions of benzodiazepine tranquilizers, it is quite possible that the drugs actually act indirectly to reduce serotonin activity. The concept that benzodiazepines may exert a primary action on GABA-containing neurons, which in turn regulate serotonergic transmission, was supported by preliminary psychopharmacological evidence. The GABA-antagonist picrotoxin, at doses that do not disrupt unpunished behavior, fully antagonizes the punishment-lessening effects of benzodiazepines in the conflict test.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 242201

Source DB:  PubMed          Journal:  Adv Biochem Psychopharmacol        ISSN: 0065-2229


  14 in total

1.  Alterations in brain 5-hydroxytryptamine metabolism during the 'withdrawal' phase after chronic treatment with diazepam and bromazepam.

Authors:  R A Agarwal; Y D Lapierre; R B Rastogi; R L Singhal
Journal:  Br J Pharmacol       Date:  1977-05       Impact factor: 8.739

Review 2.  Drugs and depression.

Authors:  F A Whitlock; L E Evans
Journal:  Drugs       Date:  1978-01       Impact factor: 9.546

Review 3.  Chemical structure and biological activity of the diazepines.

Authors:  P Danneberg; K H Weber
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

4.  In vitro studies on GABA release.

Authors:  U Schacht; G Bäcker
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

5.  The effects of compounds related to gamma-aminobutyrate and benzodiazepine receptors on behavioural responses to anxiogenic stimuli in the rat: extinction and successive discrimination.

Authors:  C Buckland; J Mellanby; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  Benzodiazepines reduce the tolerance to reward delay in rats.

Authors:  M H Thiébot; C Le Bihan; P Soubrié; P Simon
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Evidence against the involvement of serotonergic neurons in the anti-punishment activity of diazepam in the rat.

Authors:  M H Thiébot; P Soubrié; M Hamon; P Simon
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Exposure to an open-field arena increases c-Fos expression in a subpopulation of neurons in the dorsal raphe nucleus, including neurons projecting to the basolateral amygdaloid complex.

Authors:  M W Hale; A Hay-Schmidt; J D Mikkelsen; B Poulsen; J A Bouwknecht; A K Evans; C E Stamper; A Shekhar; C A Lowry
Journal:  Neuroscience       Date:  2008-10-04       Impact factor: 3.590

9.  The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5-HT release in the frontal cortex of freely-moving rats.

Authors:  C H Cheng; B Costall; J Ge; R J Naylor
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

10.  Influence of some agents that affect 5-hydroxytryptamine metabolism and receptors on nitrazepam-induced sleep in mice.

Authors:  C Wambebe
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.